Starling Oncology (STLNW) Revenue Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Revenue Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 5.17% |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn | 24.99% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 4.16% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 10.03% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 21.39% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.75 Bn | - | 4.04% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 5.30% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | 2.75% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 8.47% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 34.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.62% |
| Mar 31, 2026 | 41.22% |
| Dec 31, 2025 | 41.58% |
| Sep 30, 2025 | 36.70% |
| Jun 30, 2025 | 21.53% |
| Mar 31, 2025 | 10.29% |
| Dec 31, 2024 | 16.88% |
| Sep 30, 2024 | 21.78% |
| Jun 30, 2024 | 22.88% |
| Mar 31, 2024 | 24.25% |
| Dec 31, 2023 | 20.11% |
| Sep 30, 2023 | 26.25% |
| Jun 30, 2023 | 31.69% |
| Mar 31, 2023 | 38.13% |
| Dec 31, 2022 | 36.56% |
| Sep 30, 2022 | 24.30% |
| Jun 30, 2022 | 22.22% |
| Mar 31, 2022 | 13.55% |